Aerie Pharma (AERI) Misses Q3 EPS by 7c
Get Alerts AERI Hot Sheet
Join SI Premium – FREE
Aerie Pharma (NASDAQ: AERI) reported Q3 EPS of ($0.71), $0.07 worse than the analyst estimate of ($0.64).
For earnings history and earnings-related data on Aerie Pharma (AERI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Mannatech (MTEX) Tops Q2 EPS by 53c
- Stantec (STN) Tops Q2 EPS by 47c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share